טוען...
Melanoma brain metastases: review of histopathological features and immune-molecular aspects
Patients with melanoma brain metastases (MBM) have a dismal prognosis, but the unprecedented advances in systemic therapy alone or in combination with local therapy have now extended the 1-year overall survival rate from 20–25% to nearing 80–85%, mainly in asymptomatic patients. The histopathologica...
שמור ב:
| הוצא לאור ב: | Melanoma Manag |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Future Medicine Ltd
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7426753/ https://ncbi.nlm.nih.gov/pubmed/32821376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt-2019-0021 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|